Patents by Inventor Julia Cochran

Julia Cochran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CAMPTOTHECIN PEPTIDE CONJUGATES
    Publication number: 20250135018
    Abstract: Provided herein are Camptothecin Conjugates, Camptothecin-Linker Compounds, Camptothecin Compounds, intermediates thereof, and method of preparing the same. Also provided herein are methods of treating cancer and autoimmune diseases with the Conjugates described herein.
    Type: Application
    Filed: October 27, 2023
    Publication date: May 1, 2025
    Inventors: Scott JEFFREY, Ryan LYSKI, Maureen RYAN, Julia COCHRAN
  • CAMPTOTHECIN PEPTIDE CONJUGATES
    Publication number: 20240277860
    Abstract: Provided herein are Camptothecin Conjugates, Camptothecin-Linker Compounds, Camptothecin Compounds, intermediates thereof, and method of preparing the same. Also provided herein are methods of treating cancer and autoimmune diseases with the Conjugates described herein.
    Type: Application
    Filed: October 2, 2020
    Publication date: August 22, 2024
    Inventors: Scott C. JEFFREY, Ryan LYSKI, Julia COCHRAN
  • CAMPTOTHECIN PEPTIDE CONJUGATES
    Publication number: 20220193069
    Abstract: Provided herein are Camptothecin Conjugates, Camptothecin-Linker Compounds, Camptothecin Compounds, intermediates thereof, and method of preparing the same. Also provided herein are methods of treating cancer and autoimmune diseases with the Conjugates described herein.
    Type: Application
    Filed: October 27, 2021
    Publication date: June 23, 2022
    Inventors: Scott JEFFREY, Ryan Lyski, Maureen Ryan, Julia Cochran
  • CAMPTOTHECIN PEPTIDE CONJUGATES
    Publication number: 20190343828
    Abstract: Provided herein are Camptothecin Conjugates, Camptothecin-Linker Compounds, Camptothecin Compounds, intermediates thereof, and method of preparing the same. Also provided herein are methods of treating cancer and autoimmune diseases with the Conjugates described herein.
    Type: Application
    Filed: April 5, 2019
    Publication date: November 14, 2019
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Scott Jeffrey, Ryan Lyski, Maureen Ryan, Julia Cochran